# Asclemed USA Inc. dba Enovachem Pharmaceuticals – FDA Inspection, Oct 12, 2017

Source: https://www.keypedia.com/records/fda_inspections/asclemed-usa-inc-dba-enovachem-pharmaceuticals/7f4c0a1a-1fbe-487e-99f1-159e81ab9865
Source feed: FDA_Inspections

> FDA inspection 1029155 of Asclemed USA Inc. dba Enovachem Pharmaceuticals, October 12, 2017. 1 citation under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1029155
- Company Name: Asclemed USA Inc. dba Enovachem Pharmaceuticals
- Inspection Date: 2017-10-12
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Los Angeles District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1263548 - 2025-03-05
- FDA Inspection 1111700 - 2019-11-05
- [FDA Inspection 1067059 - 2018-09-27](https://www.keypedia.com/records/fda_inspections/asclemed-usa-inc-dba-enovachem-pharmaceuticals/6f1a6e9b-11cc-426d-aea3-aaa665e9f2a9)
- FDA Inspection 937934 - 2015-07-15
- FDA Inspection 828037 - 2013-04-18

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)

Company: https://www.keypedia.com/companies/asclemed-usa-inc-dba-enovachem-pharmaceuticals/4accbf56-7f89-4c0a-8196-1290061fb20e

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b